Late Breaking Abstract - Efficacy and safety of benralizumab in patients with severe uncontrolled asthma despite ICS-LABA: a randomised, double-blind, placebo-controlled phase 3 trial in Asia (MIRACLE)

被引：0
|
作者：
Lai, Kefang [1 ]
Sun, Dejun [2 ]
Dai, Ranran [3 ]
Samoro, Ronnie [4 ]
Park, Hae-Sim [5 ]
Astrand, Annika [6 ]
Cohen, David [7 ]
Jison, Maria [7 ]
Shih, Vivian [8 ]
Werkstrom, Viktoria [6 ]
Yao, Yuhui [9 ]
Zhang, Yajuan [9 ]
Zheng, Wenying [10 ]
Zhong, Nanshan [1 ]
机构：
[1] Guangzhou Med Univ, State Key Lab Resp Dis, Natl Clin Res Ctr Resp Dis, Guangzhou Inst Resp Hlth,Affiliated Hosp 1, Guangzhou, Peoples R China
[2] Inner Mongolia Peoples Hosp, Hohhot, Peoples R China
[3] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Shanghai, Peoples R China
[4] Healthlink Med Surg Dent Clin & Diagnost Ctr, Iloilo, Philippines
[5] Ajou Univ Hosp, Suwon, South Korea
[6] AstraZeneca, Late Stage Resp & Immunol, Gothenburg, Sweden
[7] AstraZeneca, Late Stage Resp & Immunol, Gaithersburg, MD USA
[8] AstraZeneca, BioPharmaceut Med, Gaithersburg, MD USA
[9] AstraZeneca, Resp & Immunol, R&D China, Shanghai, Peoples R China
[10] AstraZeneca, R&D China, Biometr, Shanghai, Peoples R China
来源：
EUROPEAN RESPIRATORY JOURNAL | 2023年 / 62卷
关键词：
D O I：
10.1183/13993003.congress-2023.PA4130
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Late Breaking Abstract - The impact of regular bisoprolol on recovery with salbutamol in asthma; a double-blind randomised controlled trial
    Bennett, Miriam
    Hancox, Bob
    Chang, Cat
    Tuffery, Chris
    Hopping, Sandra
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [32] Efficacy and safety of rifampicin for multiple system atrophy: a randomised, double-blind, placebo-controlled trial
    Low, Phillip A.
    Robertson, David
    Gilman, Sid
    Kaufmann, Horacio
    Singer, Wolfgang
    Biaggioni, Italo
    Freeman, Roy
    Perlman, Susan
    Hauser, Robert A.
    Cheshire, William
    Lessig, Stephanie
    Vernino, Steven
    Mandrekar, Jay
    Dupont, William D.
    Chelimsky, Thomas
    Galpern, Wendy R.
    LANCET NEUROLOGY, 2014, 13 (03): : 268 - 275
  • [33] Safety and efficacy of natalizumab in patients with acute ischaemic stroke (ACTION): a randomised, placebo-controlled, double-blind phase 2 trial
    Elkins, Jacob
    Veltkamp, Roland
    Montaner, Joan
    Johnston, S. Claiborne
    Singhal, Aneesh B.
    Becker, Kyra
    Lansberg, Maarten G.
    Tang, Weihua
    Chang, Ih
    Muralidharan, Kumar
    Gheuens, Sarah
    Mehta, Lahar
    Elkind, Mitchell S. V.
    LANCET NEUROLOGY, 2017, 16 (03): : 217 - 226
  • [34] Baricitinib in juvenile idiopathic arthritis: an international, phase 3, randomised, double-blind, placebo-controlled, withdrawal, efficacy, and safety trial
    Ramanan, Athimalaipet, V
    Quartier, Pierre
    Okamoto, Nami
    Foeldvari, Ivan
    Spindler, Alberto
    Fingerhutova, Sarka
    Anton, Jordi
    Wang, Zhongkai
    Meszaros, Gabriella
    Araujo, Joana
    Liao, Ran
    Keller, Stuart
    LANCET, 2023, 402 (10401): : 555 - 570
  • [35] Safety and efficacy of teriflunomide in paediatric multiple sclerosis (TERIKIDS): a multicentre, double-blind, phase 3, randomised, placebo-controlled trial
    Chitnis, Tanuja
    Banwell, Brenda
    Kappos, Ludwig
    Arnold, Douglas L.
    Guecueyener, Kivilcim
    Deiva, Kumaran
    Skripchenko, Natalia
    Cui, Li-Ying
    Saubadu, Stephane
    Hu, Wenruo
    Benamor, Myriam
    Le-Halpere, Annaig
    Truffinet, Philippe
    Tardieu, Marc
    LANCET NEUROLOGY, 2021, 20 (12): : 1001 - 1011
  • [36] Liberty Asthma QUEST: Phase 3 Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate Dupilumab Efficacy/Safety in Patients with Uncontrolled, Moderate-to-Severe Asthma
    William W. Busse
    Jorge F. Maspero
    Klaus F. Rabe
    Alberto Papi
    Sally E. Wenzel
    Linda B. Ford
    Ian D. Pavord
    Bingzhi Zhang
    Heribert Staudinger
    Gianluca Pirozzi
    Nikhil Amin
    Bolanle Akinlade
    Laurent Eckert
    Jingdong Chao
    Neil M. H. Graham
    Ariel Teper
    Advances in Therapy, 2018, 35 : 737 - 748
  • [37] Randomised placebo-controlled double-blind trial to assess safety and efficacy of erythropoietin in patients with Friedreich's ataxia
    Mariotti, C.
    Fancellu, R.
    Nanetti, L.
    Solari, A.
    Martini, A.
    Di Bella, D.
    Plumari, M.
    Lauria, G.
    Cappellini, M. D.
    Taroni, F.
    JOURNAL OF NEUROLOGY, 2008, 255 : 65 - 66
  • [38] Liberty Asthma QUEST: Phase 3 Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate Dupilumab Efficacy/Safety in Patients with Uncontrolled, Moderate-to-Severe Asthma
    Busse, William W.
    Maspero, Jorge F.
    Rabe, Klaus F.
    Papi, Alberto
    Wenzel, Sally E.
    Ford, Linda B.
    Pavord, Ian D.
    Zhang, Bingzhi
    Staudinger, Heribert
    Pirozzi, Gianluca
    Amin, Nikhil
    Akinlade, Bolanle
    Eckert, Laurent
    Chao, Jingdong
    Graham, Neil M. H.
    Teper, Ariel
    ADVANCES IN THERAPY, 2018, 35 (05) : 737 - 748
  • [39] Azithromycin for prevention of exacerbations in severe asthma (AZISAST): a multicentre randomised double-blind placebo-controlled trial
    Brusselle, Guy G.
    VanderStichele, Christine
    Jordens, Paul
    Deman, Rene
    Slabbynck, Hans
    Ringoet, Veerle
    Verleden, Geert
    Demedts, Ingel K.
    Verhamme, Katia
    Delporte, Anja
    Demeyere, Benedicte
    Claeys, Geert
    Boelens, Jerina
    Padalko, Elizaveta
    Verschakelen, Johny
    Van Maele, Georges
    Deschepper, Ellen
    Joos, Guy F. P.
    THORAX, 2013, 68 (04) : 322 - 329
  • [40] Efficacy and safety of fasudil in patients with stable angina - A double-blind, placebo-controlled, phase 2 trial
    Vicari, RM
    Chaitman, B
    Keefe, D
    Smith, WB
    Chrysant, SG
    Tonkon, MJ
    Bittar, N
    Weiss, RJ
    Morales-Ballejo, H
    Thadani, U
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (10) : 1803 - 1811
12345